IMMUNE CHECKPOINT THERAPY
Clinical trials for IMMUNE CHECKPOINT THERAPY explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT THERAPY trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Low-Dose radiation plus immunotherapy shows promise for tough colon cancers
Disease control Recruiting nowThis study tests a new approach for people with a hard-to-treat type of colon cancer (pMMR/MSS). The treatment combines low-dose radiation (sparing lymph nodes), chemotherapy, and an immunotherapy drug (PD-1 inhibitor) before surgery. The goal is to see if this combination can ma…
Matched conditions: IMMUNE CHECKPOINT THERAPY
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo therapy aims to boost colon cancer treatment response
Disease control Recruiting nowThis study tests a new approach for people with a common type of high-risk colon cancer that doesn't respond well to immunotherapy alone. The treatment combines a special type of radiation that spares lymph nodes, followed by chemotherapy and an immunotherapy drug. The goal is to…
Matched conditions: IMMUNE CHECKPOINT THERAPY
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Heart watch: new study aims to protect cancer Patients' hearts during immunotherapy
Knowledge-focused Recruiting nowThis study looks at whether regularly checking a heart enzyme called troponin in cancer patients receiving immune checkpoint inhibitors can help reduce heart-related side effects. About 980 adults who are starting this type of immunotherapy will be monitored. The goal is to see i…
Matched conditions: IMMUNE CHECKPOINT THERAPY
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:44 UTC